MAXALT-RPD 5mg oral lyophilisate MERCK SHARP DOHME
Active substance: rizatriptan
N02CC04 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists
Indicated for: migraine
Find medicines for human use by name or active substance.
Browse by initial
141–160 of 1,296 medicines
Active substance: rizatriptan
N02CC04 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists
Indicated for: migraine
Active substance: dexamethasone
S01BA01 Sensory organs | Antiinflammatory agents | Corticosteroids, plain
Indicated for: inflammation; cancer; COVID-19
Active substance: dexamethasone
S01BA01 Sensory organs | Antiinflammatory agents | Corticosteroids, plain
Indicated for: inflammation; cancer; COVID-19
Active substance: dexamethasone
S01BA01 Sensory organs | Antiinflammatory agents | Corticosteroids, plain
Indicated for: inflammation; cancer; COVID-19
Active substance: cefuroxime
Indicated for: bacterial infections
Active substance: cefuroxime
Indicated for: bacterial infections
Active substance: cefepime
Indicated for: bacterial infections
Active substance: cefepime
Indicated for: bacterial infections
Active substance: acetylsalicylic acid
N02BA01 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives
Indicated for: pain; fever
Active substance: acetylsalicylic acid + ascorbic acid
N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives
Indicated for: cold and flu symptoms
Active substance: neomycin + dexamethasone + polymyxin
Indicated for: bacterial infections
Active substance: dutasteride
Indicated for: benign prostatic hyperplasia
Active substance: isosorbide dinitrate
C01DA08 Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates
Indicated for: angina pectoris
Active substance: sitagliptin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: sitagliptin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: sitagliptin
Indicated for: type 2 diabetes mellitus
Active substance: sitagliptin
Indicated for: type 2 diabetes mellitus
Active substance: sitagliptin
Indicated for: type 2 diabetes mellitus
Active substance: siponimod
Indicated for: multiple sclerosis
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.